'Animal rule' diaporamas de présentation

NIAID BioDefense Research: Challenges, Opportunities, & Sustainability

NIAID BioDefense Research: Challenges, Opportunities, & Sustainability. Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director, BioDefense Product Development

454 views • 27 slides

Perspectives on the Animal Rule What is the Animal Rule? The Basics

462 views • 27 slides

Jean L. Patterson, Ph.D. Chair, Department of Virology and Immunology

Vaccine Development at Animal Biosafety Level Four: Standards and Challenges. Jean L. Patterson, Ph.D. Chair, Department of Virology and Immunology. Texas Biomed BSL4 PIs: Ricardo Carrion, Jr., Ph.D. Robert Davey, Ph.D. Anthony Griffiths, Ph.D. Andrew Hayhurst, Ph.D .

348 views • 22 slides

Anthrax

Pathway to Licensure for Protective Antigen-based Anthrax Vaccines for a Post-exposure Prophylaxis Indication Using the Animal Rule. Anthrax. From Collier and Young, Sci. Am. March 2002. Mechanism of Action of Anthrax Toxin. PA-based Anthrax Vaccine Design. Based on PA

457 views • 17 slides

Office of Biotechnology Products

Office of Biotechnology Products. Site Visit Report Cellular, Tissue, and Gene Therapies Advisory Committee Meeting April 17, 2013. Steven Kozlowski, Director, OBP Edward Max, Assoc. Dir. Research, OBP. Office of Biotechnology Products (OBP) Steven Kozlowski, MD, Director

286 views • 14 slides

"State of the Industry" Regarding Animal Model Development and Using the Animal Rule for Licensure

"State of the Industry" Regarding Animal Model Development and Using the Animal Rule for Licensure. Doris Snow, Ph.D. 1,2 1 Vaccines Subgroup of Alliance for Biosecurity 2 DynPort Vaccine Company LLC, A CSC Company, Frederick, MD. Introduction

169 views • 1 slides